Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ivana Kutle

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Pathogens (Basel, Switzerland)|July 29, 2023
Mouse Models for Human HerpesvirusesIvana Kutle, Anne Dittrich, Dagmar Wirth
Cancers|May 13, 2023
Tumor Organoid and Spheroid Models for Cervical CancerIvana Kutle, Robert Polten, Jens Hachenberg, et al.
Cancers|January 8, 2023
Towards Novel Gene and Cell Therapy Approaches for Cervical CancerRobert Polten, Ivana Kutle, Jens Hachenberg, et al.
Scientific Reports|November 16, 2017
The M25 gene products are critical for the cytopathic effect of mouse cytomegalovirusIvana Kutle, Sarah Sengstake, Corinna Templin, et al.
Journal of Virology|July 31, 2020
Murine Cytomegalovirus M25 Proteins Sequester the Tumor Suppressor Protein p53 in Nuclear AccumulationsIvana Kutle, Katarzyna M Szymańska-de Wijs, Boris Bogdanow, et al.
The EMBO Journal|December 29, 2016
Fluorescence-based ATG8 sensors monitor localization and function of LC3/GABARAP proteinsAlexandra Stolz, Mateusz Putyrski, Ivana Kutle, et al.
Oncoimmunology|September 17, 2025
Anti-FAP CAR-NK cells as a novel targeted therapy against cervical cancer and cancer-associated fibroblastsRobert Polten, Ivana Kutle, Jan Lennart Stalp, et al.
Cancers|June 28, 2023
CAR-NK Cells Targeting HER1 (EGFR) Show Efficient Anti-Tumor Activity against Head and Neck Squamous Cell Carcinoma (HNSCC)Juliette Nowak, Marco Bentele, Ivana Kutle, et al.
Frontiers in Immunology|March 10, 2025
Corrigendum: Anti-Mesothelin CAR-NK cells as a novel targeted therapy against cervical cancerIvana Kutle, Robert Polten, Jan Lennart Stalp, et al.
Frontiers in Immunology|January 9, 2025
Anti-Mesothelin CAR-NK cells as a novel targeted therapy against cervical cancerIvana Kutle, Robert Polten, Jan Lennart Stalp, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Pathogens (Basel, Switzerland)|July 29, 2023
Mouse Models for Human HerpesvirusesIvana Kutle, Anne Dittrich, Dagmar Wirth
Cancers|May 13, 2023
Tumor Organoid and Spheroid Models for Cervical CancerIvana Kutle, Robert Polten, Jens Hachenberg, et al.
Cancers|January 8, 2023
Towards Novel Gene and Cell Therapy Approaches for Cervical CancerRobert Polten, Ivana Kutle, Jens Hachenberg, et al.
Scientific Reports|November 16, 2017
The M25 gene products are critical for the cytopathic effect of mouse cytomegalovirusIvana Kutle, Sarah Sengstake, Corinna Templin, et al.
Journal of Virology|July 31, 2020
Murine Cytomegalovirus M25 Proteins Sequester the Tumor Suppressor Protein p53 in Nuclear AccumulationsIvana Kutle, Katarzyna M Szymańska-de Wijs, Boris Bogdanow, et al.
The EMBO Journal|December 29, 2016
Fluorescence-based ATG8 sensors monitor localization and function of LC3/GABARAP proteinsAlexandra Stolz, Mateusz Putyrski, Ivana Kutle, et al.
Oncoimmunology|September 17, 2025
Anti-FAP CAR-NK cells as a novel targeted therapy against cervical cancer and cancer-associated fibroblastsRobert Polten, Ivana Kutle, Jan Lennart Stalp, et al.
Cancers|June 28, 2023
CAR-NK Cells Targeting HER1 (EGFR) Show Efficient Anti-Tumor Activity against Head and Neck Squamous Cell Carcinoma (HNSCC)Juliette Nowak, Marco Bentele, Ivana Kutle, et al.
Frontiers in Immunology|March 10, 2025
Corrigendum: Anti-Mesothelin CAR-NK cells as a novel targeted therapy against cervical cancerIvana Kutle, Robert Polten, Jan Lennart Stalp, et al.
Frontiers in Immunology|January 9, 2025
Anti-Mesothelin CAR-NK cells as a novel targeted therapy against cervical cancerIvana Kutle, Robert Polten, Jan Lennart Stalp, et al.
Pageof 1